The vast world of cellular regulation is populated with a diverse range of proteins, each playing its own unique role in maintaining the intricate balance of cellular processes. Among these, ANKRD10, or Ankyrin Repeat Domain 10, stands as a representative of the ankyrin repeat-containing protein family. These proteins are characterized by the presence of ankyrin repeats, a common protein motif involved in mediating protein-protein interactions. As ANKRD10 engages in its roles within the cellular environment, it becomes a focal point of interest for researchers aiming to modulate its activity, leading to the conceptual development of ANKRD10 inhibitors.
ANKRD10 inhibitors, by definition, are chemical compounds designed to specifically interfere with the function and activity of the ANKRD10 protein. The mechanism by which these inhibitors operate can vary. Some might directly bind to the protein, blocking its active or binding sites and rendering it inactive. Others might target the synthesis, folding, or degradation processes of the protein, thus regulating its abundance within the cell. The challenge with developing specific inhibitors for a protein like ANKRD10 lies in ensuring specificity. Given the widespread occurrence of ankyrin repeats in various proteins, it becomes paramount to design inhibitors that solely target ANKRD10 without inadvertently affecting other proteins of the ankyrin family. The understanding and development of ANKRD10 inhibitors is an evolving field. As science delves deeper into the nuances of cellular regulation and protein interaction networks, the quest for deciphering and modulating the roles of proteins like ANKRD10 becomes an ever-exciting journey in molecular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cardamonin | 19309-14-9 | sc-293984 sc-293984A | 10 mg 50 mg | $224.00 $940.00 | ||
Known to inhibit NF-kappaB, which contains ankyrin repeats. Might influence ANKRD10's interaction or stability. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
Inhibits IkBα, an ankyrin repeat-containing protein. Could have off-target effects on ANKRD10. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-kappaB activation. Might affect ANKRD10 indirectly through cellular signaling. | ||||||
IMD 0354 | 978-62-1 | sc-203084 | 5 mg | $199.00 | 3 | |
IKKβ inhibitor affecting NF-kappaB pathway. Potential indirect effects on ANKRD10. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Known to inhibit NF-kappaB activation. Potential indirect effects on ANKRD10's function or stability. | ||||||
Wedelolactone | 524-12-9 | sc-200648 sc-200648A | 1 mg 5 mg | $110.00 $337.00 | 8 | |
Inhibits IKK, affecting NF-kappaB signaling. Might influence ANKRD10 indirectly. | ||||||
QNZ | 545380-34-5 | sc-200675 | 1 mg | $117.00 | 12 | |
Suppresses NF-kappaB activation. Potential indirect effects on ANKRD10 through cellular signaling pathways. | ||||||
Tanshinone IIA | 568-72-9 | sc-200932 sc-200932A | 5 mg 25 mg | $88.00 $316.00 | 22 | |
Known to inhibit NF-kappaB and might affect ANKRD10 indirectly. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Affects NF-kappaB signaling. Might have indirect effects on ANKRD10. | ||||||
Caffeic Acid | 331-39-5 | sc-200499 sc-200499A | 1 g 5 g | $32.00 $62.00 | 1 | |
Inhibits NF-kappaB activation. Potential indirect effects on ANKRD10's function. | ||||||